Skip to main content

The Toronto Symphony Orchestra, is pictured during a rehearsal at Roy Thomson Hall on Jan 26 2015.

Fred Lum/The Globe and Mail

The Toronto Symphony Orchestra faces an unexpected $4-million-plus annual deficit in the wake of the sudden departure of chief executive officer Jeff Melanson, but the country's leading orchestra is contemplating a novel approach to funding the shortfall: Sell a rare viola to its own foundation.

According to sources at the TSO, one of Canada's oldest and largest musical institutions expects to post a $4-million-to-$6-million deficit for the current financial year, which ends on June 30, due to higher-than-expected spending on programs and administration.

Last year, the TSO ran a $135,781 surplus on revenues of $28-million, its second consecutive year in the black.

Story continues below advertisement

The projected red ink comes after Mr. Melanson resigned in March, 18 months into a five-year term as CEO. The departure followed allegations of personal and professional impropriety by Mr. Melanson, outlined in court documents filed by his estranged wife.

Sonia Baxendale, a TSO board member and former senior executive at CIBC, was named interim CEO.

"There were commitments made by Melanson that were more expensive than anticipated," said a TSO board member, who asked for anonymity because directors are not authorized to speak to media. The TSO is also understood to be paying a significant severance to Mr. Melanson. However, board members and executives familiar with the institution said Ms. Baxendale and the TSO management team are on top of the problem and have a plan to tune up the orchestra's finances.

A spokesperson for the TSO could not be reached for comment.

Part of the fix, according to multiple sources at the TSO, is to transfer ownership of a rare viola that was donated to the orchestra to the Toronto Symphony Foundation, which has assets of $34.2-million. The viola has been appraised at $4-million, and sources said this amount would be transferred from the foundation to the symphony in return for ownership of the instrument. The foundation plans to keep the viola as part of the orchestra's permanent collection.

At $4-million, the valuation on the TSO instrument pales beside to the $45-million (U.S.) price attached to a Stradivarius viola put up for auction in 2014, though it's worth noting no one was willing to meet that minimum bid.

Auction house Tarisio reports that the record price paid for a musical instrument is $15-million (U.S.) for a Stradivarius violin that was sold in 2011.

Story continues below advertisement

The TSO, which drew 250,000 concert goers to 132 performances last year, pays its way with ticket sales, fundraising, government grants and contributions from its foundation. In 2015, the foundation gave the TSO $2.6-million.

While it has been in the black for the past two years, the TSO has a debt of $12-million, partly backstopped by the City of Toronto, and sources said the orchestra's board and lenders are keen on reducing this amount with initiatives such as the viola sale, rather than adding to the TSO's credit line.

The TSO is expected to launch a fundraising blitz in the remainder of its fiscal year to cover as much as possible of the rest of its anticipated shortfall. Last year, supporters donated $9.5-million, the single largest source of revenue for the institution. Sources at the TSO said the orchestra's musicians agreed to a pay freeze for the coming year during contract talks that are under way, out of concern for the institution's financial health. The 94-year-old orchestra has faced several financial crises over the years, and consistently received support from its musicians, governments and the community.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies